33 Results for "

RIP3

" in MedChemExpress (MCE) Product Catalog:
Products (33)

33 Results for "RIP3" in MCE Product Catalog:

110
110 Publications Verification
Cat. No.: HY-101872
CAS No.: 1346546-69-7
Purity:  99.80%
Target:  

RIP kinase

Research Areas:  

Inflammation/Immunology

GSK-872 is a RIPK3 inhibitor, which binds RIP3 kinase domain with an IC50 of 1.8 nM, and inhibits kinase activity with an IC50 of 1.3 nM. GSK-872 decreases the RIPK3-mediated necroptosis and subsequent cytoplasmic translocation and expression of HMGB1, as well as ameliorates brain edema and neurological deficits in early brain injury [3].
loading...
    loading...
110
110 Publications Verification
Cat. No.: HY-101872A
CAS No.: 2703752-81-0
Purity:  99.21%
Target:  

RIP kinase

Research Areas:  

Inflammation/Immunology

GSK-872 hydrochloride is a RIPK3 inhibitor, which binds RIP3 kinase domain with an IC50 of 1.8 nM, and inhibits kinase activity with an IC50 of 1.3 nM. GSK-872 hydrochloride decreases the RIPK3-mediated necroptosis and subsequent cytoplasmic translocation and expression of HMGB1, as well as ameliorates brain edema and neurological deficits in early brain injury [3].
loading...
    loading...
8
8 Cited Publications
Cat. No.: HY-125402
CAS No.: 1601496-05-2
Purity:  99.18%
Synonyms: GSK'843
Target:  

RIP kinase Apoptosis

Research Areas:  

Inflammation/Immunology

GSK-843 (GSK'843) is a receptor-interacting protein kinase 3 (RIP3 or RIPK3) inhibitor, which binds RIP3 kinase domain with an IC50 of 8.6 nM, and inhibits kinase activity with an IC50 of 6.5 nM. GSK-843 can be used for the research of inflammation .
loading...
    loading...
7
7 Cited Publications
Cat. No.: HY-144828
CAS No.: 2682850-41-3
Purity:  ≥97.0%
Research Areas:  

Cancer

RIP1/RIP3/MLKL activator 1 (Compound 6i) is a potent anti-glioma agent. RIP1/RIP3/MLKL activator 1 induces necroptosis through RIP1/RIP3/MLKL pathway. RIP1/RIP3/MLKL activator 1 exerts acceptable BBB permeability .
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-114349
CAS No.: 2158197-70-5
Purity:  99.89%
Target:  

RIP kinase

Research Areas:  

Cardiovascular Disease Cancer

HS-1371 is a potent and ATP-competitive receptor-interacting protein kinase 3 (RIP3) inhibitor with an IC50 of 20.8 nM .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-122909
CAS No.: 1337531-06-2
Purity:  99.07%
Synonyms: GSK'074
Target:  

RIP kinase

Research Areas:  

Inflammation/Immunology

GSK2593074A (GSK’074) is a necroptosis inhibitor with dual targeting ability to both RIP1 and RIP3 .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-104021
CAS No.: 2361146-30-5
Purity:  99.95%
Synonyms: GSK'840
Target:  

RIP kinase

Research Areas:  

Inflammation/Immunology

GSK840 (GSK'840) is a receptor-interacting protein kinase 3 (RIP3 or RIPK3) inhibitor, which binds RIP3 kinase domain with an IC50 of 0.9 nM, and inhibits kinase activity with an IC50 of 0.3 nM .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-N3417
CAS No.: 885315-96-8
Kongensin A is a natural product isolated from Croton kongensis. Kongensin A is an effective, covalent HSP90 inhibitor that blocks RIP3-dependent necroptosishas. Kongensin A is a potent necroptosis inhibitor and an apoptosis inducer. Kongensin A has potential anti-necroptosis and anti-inflammation applications .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-100904
CAS No.: 89196-95-2
Purity:  99.82%
Synonyms: 2 BFI
RX 801077 hydrochloride (2 BFI) is a selective imidazoline I2 receptor (I2R) agonist with a Ki value of 70.1 nM. RX 801077 hydrochlorideshows anti-inflammation and neuroprotection. RX 801077 hydrochloride has the potential for the research of traumatic brain injury (TBI) .
loading...
    loading...
Cat. No.: HY-162424
CAS No.: 3057611-79-4
Research Areas:  

Cancer

ZBP1/RIP3/MLKL activator 1 (compound 3a) is a synthetically derived quinoline compound. ZBP1/RIP3/MLKL Activator 1 induces DNA damage, enhances intracellular levels of reactive oxygen species (ROS), and triggers apoptosis via the caspase pathway. Furthermore, when apoptosis is inhibited, ZBP1/RIP3/MLKL Activator 1 promotes necroptotic cell death through the ZBP1-RIP3-MLKL pathway. ZBP1/RIP3/MLKL Activator 1 is utilized in oncological research, particularly in the selective targeting of cells with impaired apoptotic function .
loading...
    loading...
Cat. No.: HY-168640
CAS No.: 1456899-52-7
Research Areas:  

Cancer

RIP3 activator 1 (compound C8) is a potent RIP3 activator. RIP3 activator 1 inhibits cell growth. RIP3 activator 1 induces necroptosis through the RIP3/p62/Keap1 signaling pathway. RIP3 activator 1 increases the protein expression of p-MLKL. RIP3 activator 1 induces autophagy. RIP3 activator 1 increases accumulation of LC3-II and p62 protein expression .
loading...
    loading...
Cat. No.: HY-148767
CAS No.: 2755872-58-1
Research Areas:  

Others

MLKL-IN-5 is a mixed lineage kinase domain-like protein (MLKL) inhibitor with a KD of < 10 nM. MLKL-IN-5 exhibits selectivity for RIP3 and RIP1, with KD values of 1-30 μM and > 30 μM, respectively. MLKL-IN-5 mediates necroptosis .
loading...
    loading...
Cat. No.: HY-173185
Target:  

RIP kinase Necroptosis

Research Areas:  

Inflammation/Immunology

RIP1-IN-1 is an orally active RIP1 inhibitor with strong RIP1 binding affinity (Kd: 110 nM). RIP1-IN-1 exhibits strong anti-necroptosis activity. RIP1-IN-1 effectively inhibits the formation of necrosomes by blocking the phosphorylation of RIP1, RIP3 and MLKL signaling pathways. RIP1-IN-1 inhibits necroptosis and can be used in the study of acute liver injury .
loading...
    loading...
Cat. No.: HY-RS11998
Research Areas:  

Others

RIPK3 Human Pre-designed siRNA Set A contains three designed siRNAs for RIPK3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-148052
CAS No.: 2665669-32-7
Target:  

RIP kinase

Research Areas:  

Cancer

RIPK3-IN-2 is a RIP3 inhibitor. RIPK3-IN-2 can be used in diseases caused by or associate with activated necrotic pathways research .
loading...
    loading...
Cat. No.: HY-N8380
CAS No.: 10154-42-4
(-)-Latifolin, a flavonoid, induces apoptotic cell death by targeting PI3K/AKT/mTOR/p70S6K signaling. (-)-Latifolin significantly inhibits the cell proliferation of oral squamous cell carcinoma (OSCC), and causes the anti-metastatic activities by effectively blocking cell migration, invasion, and adhesion via the inactivation of FAK/Src. (-)-Latifolin suppresses autophagic-related proteins and autophagosome formation. (-)-Latifolin inhibits necroptosis by dephosphorylating necroptosis-regulatory proteins (RIP1, RIP3, and MLKL). (-)-Latifolin has beneficial effects on anti-aging, anti-carcinogenic, anti-inflammatory, and cardio-protective activities .
loading...
    loading...
Cat. No.: HY-104021R
CAS No.: 2361146-30-5
Synonyms: GSK'840 (Standard)
Research Areas:  

Inflammation/Immunology

GSK840 (Standard) is the analytical standard of GSK840 (HY-104021). This product is intended for research and analytical applications. GSK840 (GSK'840) is a receptor-interacting protein kinase 3 (RIP3 or RIPK3) inhibitor, which binds RIP3 kinase domain with an IC50 of 0.9 nM, and inhibits kinase activity with an IC50 of 0.3 nM .
loading...
    loading...
Cat. No.: HY-P71853
Purity:  ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: RIPk3; RIP3; Receptor-interacting serine/threonine-protein kinase 3; EC 2.7.11.1; RIP-like protein kinase 3; Receptor-interacting protein 3; RIP-3; mRIP3
Species:  
Source:  
loading...
    loading...
Cat. No.: HY-P86351
Synonyms: Receptor-interacting serine/threonine-protein kinase 3, RIPK3,RIP3

Host:  

Rabbit

Application:  

WB, ICC/IF, IP, ELISA

Reactivity:  

Mouse

loading...
    loading...
Cat. No.: HY-RS11999
Research Areas:  

Others

Ripk3 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Ripk3 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...